Azasetron Hydrochloride-13C, d3
Azasetron Hydrochloride-13C, d3 is the deuterium and 13C-labeled Azasetron. Azasetron ((Rac) -SENS-401 free base) is an antiemetic drug with 5-HT3 receptor antagonist activity. Azasetron is often used as a preventive measure for postoperative nausea and vomiting or chemotherapy-induced nausea and vomiting. Azasetron does not impair neutrophil chemotaxis or phagocytosis and does not scavenge O (-) (2) or H (2) O (2) generated by cell-free systems[1].
Product Specifications
CAS Number
1329611-23-5
UNSPSC
12352005
Target
5-HT Receptor; Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
[2H][13C]([2H])(N1C(COC2=C1C=C(Cl)C=C2C(NC3CN4CCC3CC4)=O)=O)[2H].Cl
Molecular Formula
C16 13CH18D3Cl2N3O3
Molecular Weight
390.28
References & Citations
[1]Effects of ondansetron, granisetron, ramosetron, and azasetron on human neutrophil functions
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF740 conjugate, 0.1mg/mL
Mucin 5AC (MUC5AC) (45M1), CF568 conjugate, 0.1mg/mL
Cytokeratin 8 (K8/383), CF640R conjugate, 0.1mg/mL
Ep-CAM / CD326 (Epithelial Marker) (rMOC-31), CF594 conjugate, 0.1mg/mL
